Annual ROE:
14.16%+1.48%(+11.67%)Summary
- As of today, NBIX annual return on equity is 14.16%, with the most recent change of +1.48% (+11.67%) on December 31, 2024.
- During the last 3 years, NBIX annual ROE has risen by +6.99% (+97.49%).
- NBIX annual ROE is now -85.03% below its all-time high of 94.61%, reached on December 31, 2011.
Performance
NBIX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
13.35%+1.35%(+11.25%)Summary
- As of today, NBIX quarterly return on equity is 13.35%, with the most recent change of +1.35% (+11.25%) on June 30, 2025.
- Over the past year, NBIX quarterly ROE has dropped by -2.09% (-13.54%).
- NBIX quarterly ROE is now -90.19% below its all-time high of 136.08%, reached on September 30, 2011.
Performance
NBIX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NBIX ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1Y1 Year | +11.7% | -13.5% |
3Y3 Years | +97.5% | +1383.3% |
5Y5 Years | +113.9% | -57.9% |
NBIX ROE Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
---|---|---|---|---|---|
3Y | 3-Year | at high | +97.5% | -26.6% | +224.8% |
5Y | 5-Year | -69.3% | +113.9% | -73.1% | +1383.3% |
All-Time | All-Time | -85.0% | +105.7% | -90.2% | +103.2% |
NBIX ROE History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | 13.35%(+11.3%) |
Mar 2025 | - | 12.00%(-12.5%) |
Dec 2024 | 14.16%(+11.7%) | 13.72%(-15.8%) |
Sep 2024 | - | 16.29%(+5.5%) |
Jun 2024 | - | 15.44%(-15.2%) |
Mar 2024 | - | 18.20%(+38.2%) |
Dec 2023 | 12.68%(+26.4%) | 13.17%(+21.3%) |
Sep 2023 | - | 10.86%(+1.1%) |
Jun 2023 | - | 10.74%(+160.0%) |
Mar 2023 | - | 4.13%(-60.2%) |
Dec 2022 | 10.03%(+39.9%) | 10.38%(+152.6%) |
Sep 2022 | - | 4.11%(+356.7%) |
Jun 2022 | - | 0.90%(-83.4%) |
Mar 2022 | - | 5.41%(-23.6%) |
Dec 2021 | 7.17%(-84.5%) | 7.08%(-81.7%) |
Sep 2021 | - | 38.60%(+11.0%) |
Jun 2021 | - | 34.76%(-19.3%) |
Mar 2021 | - | 43.06%(-13.3%) |
Dec 2020 | 46.20%(+597.9%) | 49.68%(+277.2%) |
Sep 2020 | - | 13.17%(-58.5%) |
Jun 2020 | - | 31.73%(+0.8%) |
Mar 2020 | - | 31.47%(+339.5%) |
Dec 2019 | 6.62%(+33.7%) | 7.16%(+62.7%) |
Sep 2019 | - | 4.40%(+7.1%) |
Jun 2019 | - | 4.11%(+143.6%) |
Mar 2019 | - | -9.42%(-282.2%) |
Dec 2018 | 4.95%(+111.9%) | 5.17%(+98.8%) |
Sep 2018 | - | 2.60%(+118.1%) |
Jun 2018 | - | -14.38%(+54.5%) |
Mar 2018 | - | -31.62%(+27.8%) |
Dec 2017 | -41.50%(-8.7%) | -43.81%(+27.5%) |
Sep 2017 | - | -60.41%(+9.9%) |
Jun 2017 | - | -67.03%(-14.4%) |
Mar 2017 | - | -58.60%(-56.6%) |
Dec 2016 | -38.17%(-35.9%) | -37.42%(-20.1%) |
Sep 2016 | - | -31.17%(-7.8%) |
Jun 2016 | - | -28.91%(-20.8%) |
Mar 2016 | - | -23.93%(-9.4%) |
Dec 2015 | -28.09%(+23.6%) | -21.88%(-1.4%) |
Sep 2015 | - | -21.58%(-15.6%) |
Jun 2015 | - | -18.66%(-4.8%) |
Mar 2015 | - | -17.80%(+39.0%) |
Dec 2014 | -36.79%(-9.7%) | -29.19%(-8.1%) |
Sep 2014 | - | -27.01%(+0.0%) |
Jun 2014 | - | -27.02%(+8.3%) |
Mar 2014 | - | -29.48%(+12.4%) |
Dec 2013 | -33.55%(-815.4%) | -33.64%(-83.5%) |
Sep 2013 | - | -18.33%(-48.1%) |
Jun 2013 | - | -12.38%(-193.4%) |
Mar 2013 | - | -4.22%(-208.5%) |
Dec 2012 | 4.69%(-95.0%) | 3.89%(+236.5%) |
Sep 2012 | - | -2.85%(-107.9%) |
Jun 2012 | - | 36.26%(-33.4%) |
Mar 2012 | - | 54.48%(-46.1%) |
Dec 2011 | 94.61%(+238.3%) | 101.15%(-25.7%) |
Sep 2011 | - | 136.08%(+147.1%) |
Jun 2011 | - | 55.07%(+173.4%) |
Mar 2011 | - | 20.14%(+134.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | -68.40%(+72.7%) | -57.67%(+68.1%) |
Sep 2010 | - | -180.78%(+49.8%) |
Jun 2010 | - | -359.93%(+13.3%) |
Mar 2010 | - | -414.95%(-11.0%) |
Dec 2009 | -250.63%(-119.9%) | -373.84%(-32.9%) |
Sep 2009 | - | -281.26%(-42.7%) |
Jun 2009 | - | -197.15%(-34.8%) |
Mar 2009 | - | -146.29%(-31.3%) |
Dec 2008 | -113.99%(-19.2%) | -111.43%(+28.1%) |
Sep 2008 | - | -154.95%(-27.4%) |
Jun 2008 | - | -121.59%(-22.8%) |
Mar 2008 | - | -99.04%(-18.4%) |
Dec 2007 | -95.66%(-214.5%) | -83.65%(-157.4%) |
Sep 2007 | - | -32.50%(+4.0%) |
Jun 2007 | - | -33.87%(-6.2%) |
Mar 2007 | - | -31.88%(-5.7%) |
Dec 2006 | -30.42%(-437.5%) | -30.17%(+3.3%) |
Sep 2006 | - | -31.19%(-133.3%) |
Jun 2006 | - | -13.37%(-75.9%) |
Mar 2006 | - | -7.60%(-32.4%) |
Dec 2005 | -5.66%(+51.5%) | -5.74%(-18.8%) |
Sep 2005 | - | -4.83%(+59.3%) |
Jun 2005 | - | -11.88%(+8.2%) |
Mar 2005 | - | -12.94%(-15.0%) |
Dec 2004 | -11.66%(-18.6%) | -11.25%(-107.6%) |
Sep 2004 | - | -5.42%(+34.4%) |
Jun 2004 | - | -8.26%(+8.0%) |
Mar 2004 | - | -8.98%(+15.2%) |
Dec 2003 | -9.83%(+72.2%) | -10.59%(+62.0%) |
Sep 2003 | - | -27.85%(+19.9%) |
Jun 2003 | - | -34.79%(+4.0%) |
Mar 2003 | - | -36.23%(-4.8%) |
Dec 2002 | -35.33%(-126.9%) | -34.57%(-26.6%) |
Sep 2002 | - | -27.30%(-34.3%) |
Jun 2002 | - | -20.33%(-3.3%) |
Mar 2002 | - | -19.68%(+2.3%) |
Dec 2001 | -15.57%(+29.8%) | -20.15%(+4.0%) |
Sep 2001 | - | -21.00%(+33.2%) |
Jun 2001 | - | -31.43%(-15.8%) |
Mar 2001 | - | -27.14%(-9.0%) |
Dec 2000 | -22.18%(-11.1%) | -24.91%(+10.1%) |
Sep 2000 | - | -27.71%(-14.1%) |
Jun 2000 | - | -24.29%(+1.9%) |
Mar 2000 | - | -24.77%(-5.8%) |
Dec 1999 | -19.96%(+22.3%) | -23.42%(+19.6%) |
Sep 1999 | - | -29.13%(-7.6%) |
Jun 1999 | - | -27.07%(+10.2%) |
Mar 1999 | - | -30.13%(-17.5%) |
Dec 1998 | -25.69%(-491.0%) | -25.64%(-55.8%) |
Sep 1998 | - | -16.46%(-56.6%) |
Jun 1998 | - | -10.51%(-2665.8%) |
Mar 1998 | - | -0.38%(-105.9%) |
Dec 1997 | 6.57%(-18.5%) | 6.43%(-49.4%) |
Sep 1997 | - | 12.70%(+11.4%) |
Jun 1997 | - | 11.40%(-29.1%) |
Mar 1997 | - | 16.08%(+59.2%) |
Dec 1996 | 8.06% | 10.10%(+287.0%) |
Sep 1996 | - | 2.61%(-32.7%) |
Jun 1996 | - | 3.88% |
FAQ
- What is Neurocrine Biosciences, Inc. annual return on equity?
- What is the all-time high annual ROE for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. annual ROE year-on-year change?
- What is Neurocrine Biosciences, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. quarterly ROE year-on-year change?
What is Neurocrine Biosciences, Inc. annual return on equity?
The current annual ROE of NBIX is 14.16%
What is the all-time high annual ROE for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high annual return on equity is 94.61%
What is Neurocrine Biosciences, Inc. annual ROE year-on-year change?
Over the past year, NBIX annual return on equity has changed by +1.48% (+11.67%)
What is Neurocrine Biosciences, Inc. quarterly return on equity?
The current quarterly ROE of NBIX is 13.35%
What is the all-time high quarterly ROE for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high quarterly return on equity is 136.08%
What is Neurocrine Biosciences, Inc. quarterly ROE year-on-year change?
Over the past year, NBIX quarterly return on equity has changed by -2.09% (-13.54%)